GCG and diabetes mellitus: Native GLP-1 and GLP-1 analogues are reported to have several significant cardiovascular effects providing the opportunity to address the multifactorial issues involved in increased mortality and morbidity associated with T2D as well as in patients with cardiac disease and no diabetes [8].